Doi.org/10.1126/scitranslmed.aad6095

Revision as of 21:06, 17 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis; H. Wang et al.; Science Translational Medicine; 2016; https://doi.org/10.1126/scitranslmed.aad6095 == Article providing comments == Comment on ""NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis""; Decalf, J.; da Silva, R. B.; Werneke, S.; Albert, M. L.; ; Science Translational Medicine; 2016-7-27 https://doi.org/10.1126/scitranslmed.aaf9121...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Target ArticleEdit

NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis; H. Wang et al.; Science Translational Medicine; 2016; https://doi.org/10.1126/scitranslmed.aad6095

Article providing commentsEdit

Comment on ""NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis""; Decalf, J.; da Silva, R. B.; Werneke, S.; Albert, M. L.; ; Science Translational Medicine; 2016-7-27 https://doi.org/10.1126/scitranslmed.aaf9121

SummaryEdit

Note: Opened to append information.